Patents for A61P 33 - Antiparasitic agents (21,787)
01/1997
01/23/1997WO1996041877A3 Malarial pre-erythrocytic stage polypeptide molecules
01/22/1997EP0754045A1 Halofantrine free base for the treatment of malaria and compositions
01/22/1997EP0553106B1 Anticoccidial and growth promoting polycyclic ether antibiotic
01/22/1997CN1141044A Antiparasitic agents
01/21/1997US5596122 Use of disulfonyl methanes for the control of parasites
01/21/1997US5596002 Treatment of antibiotic resistant microorganisms
01/21/1997US5595992 Substituted pyridines and pyrimidines, processes for their preparation and their use as pesticides and fungicides
01/15/1997EP0753310A1 Legionellosis vaccines and methods for their production
01/15/1997EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
01/15/1997EP0753009A1 Malaria peptides
01/15/1997EP0752813A1 Inhibitors of metazoan parasite proteases
01/15/1997EP0625986B1 Oligothionucleotides
01/15/1997EP0571457B1 Iloprost effective against cerebral malaria
01/14/1997US5593990 Methods and compositions for inhibition of angiogenesis
01/09/1997WO1997000876A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
01/09/1997WO1996038165A3 Endoparasiticidal agents
01/08/1997EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes
01/07/1997US5591851 Antiviral compounds
01/07/1997US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage
01/02/1997EP0751147A1 Toxoplasma gondii antigen, its production and use
01/02/1997EP0750506A1 Broad spectrum antimicrobial compounds and methods of use
01/02/1997EP0750499A1 Carbanilide anticoccidials
01/01/1997CN1139427A Malarial aspartic protease inhibitors
12/1996
12/31/1996US5589503 Endoparasiticidal compositions
12/31/1996US5589366 Process for producing antiparasitic macrolide antibiotics
12/31/1996US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes
12/27/1996WO1996041877A2 Malarial pre-erythrocytic stage polypeptide molecules
12/27/1996WO1996041536A1 Agent for combating parasites in farmed fish
12/27/1996WO1996041534A1 Use of oxazolines for combatting ectoparasites
12/27/1996EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof
12/27/1996EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF
12/27/1996EP0749305A1 Process for making avermectin/zein compositions
12/27/1996CA2223147A1 Use of oxazolines for combatting ectoparasites
12/27/1996CA2221029A1 Malarial pre-erythrocytic stage polypeptide molecules
12/19/1996WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040234A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040233A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040108A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2224115A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/18/1996EP0748816A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748815A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748384A1 Transgenic plants for the control of animal parasites
12/17/1996US5585499 Drug delivery
12/17/1996US5585493 Parasiticides for veterinary medicine
12/12/1996DE19520936A1 Ektoparasitizide Mittel Ectoparasiticidal means
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996CN1137796A Polycyclic antiparasitic agent, process and strain for their preparation and their use
12/10/1996US5583105 Oral pharmaceutical preparation
12/05/1996WO1996038165A2 Endoparasiticidal agents
12/05/1996WO1996038140A1 Agents for use against parasitic protozoa
12/05/1996DE19520275A1 Endoparasitizide Mittel Endoparasiticides means
12/05/1996DE19519821A1 Mittel gegen parasitäre Protozoen Agents against parasitic protozoa
12/04/1996EP0745089A1 Antiparasitic agents
12/04/1996EP0745066A1 Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
12/04/1996EP0744952A1 Method for treating vascular obstructions caused by abnormal cells
11/1996
11/28/1996WO1996037512A1 Cyclic peptide antifungal agents
11/28/1996WO1996037511A1 Cyclic peptides antifungal agents
11/28/1996WO1996037510A1 Cyclic peptide antifungal agents
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996030010A3 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2220944A1 Cyclic peptide antifungal agents
11/28/1996CA2220728A1 Cyclic peptide antifungal agents
11/28/1996CA2220688A1 Cyclic peptide antifungal agents
11/27/1996EP0744406A2 Cyclic peptide antifungal agents
11/27/1996EP0744405A2 Cyclic peptide antifungal agents
11/27/1996EP0744404A2 Cyclic peptide antifungal agents
11/26/1996US5578714 DNA encoding Duffy 9pd protein
11/26/1996US5578631 Methods of combating Pneumocystis carinii pneumonia and compounds useful therefor
11/21/1996WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection
11/20/1996EP0743300A1 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/14/1996WO1996035698A1 Antimalarial organometallic iron complexes
11/14/1996WO1996035450A1 Diagnostic tests for a new spirochete, borrelia lonestari
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035436A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
11/14/1996WO1996035435A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders
11/14/1996CA2219771A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders
11/14/1996CA2219758A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
11/13/1996EP0742215A1 Cillianon, antibiotic from penicillin spe., and chemical derivatives thereof, method for their preparation and application
11/13/1996EP0741696A1 Malarial aspartic protease inhibitors
11/13/1996EP0741569A1 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria
11/12/1996US5573946 Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds
11/12/1996US5573943 Cloning and expression of a rhoptry associated protein of P. falciparum
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034631A1 Method for introducing and expressing genes in animal cells
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0727996A4 Fenbendazole formulations
11/05/1996US5571793 Combatting endoparasites in humans or animals by administering peptides